Results 161 to 170 of about 87,091 (210)

Are Dietary and Serum Advanced Glycation End Products (AGEs) Potential Contributors to Inflammation in Women with Polycystic Ovary Syndrome? [PDF]

J Clin Med
Yurt M, Gökmen-Özel H.
europepmc   +1 more source

Correction to: The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. [PDF]

Cell Death Differ
Kang R, Tang D, Schapiro NE, Livesey KM, Farkas A, Loughran P, Bierhaus A, Lotze MT, Zeh HJ.   +8 more
europepmc   +1 more source

Advanced Glycation End Products in Disease Development and Potential Interventions. [PDF]

Antioxidants (Basel)
Zhang Y, Zhang Z, Tu C, Chen X, He R.
europepmc   +1 more source

Advanced glycation end products promote the release of endothelial cell-derived mitocytosis. [PDF]

FEBS Open Bio
Liu R, Zhang Y, Ge T, Wu H, Ma Y, Ye H, Guo F.   +6 more
europepmc   +1 more source

Non-invasive evaluation of advanced glycation end products in hair as early markers of diabetes and aging. [PDF]

Sci Rep
Kato S, Satoh Y, Okamoto A, Nagai R.
europepmc   +1 more source

Relationship between advanced glycation end-products, serum carnosinase-1 and diabetic nephropathy and diabetic retinopathy. [PDF]

J Med Biochem
Rong Y.
europepmc   +1 more source

Advanced glycation end products are biomolecular biomarkers for proliferative diabetic retinopathy. [PDF]

Indian J Ophthalmol
Mishra N, Saxena S, Shukla RK, Tiwari A.
europepmc   +1 more source

Advanced glycation end‐products and the kidney [PDF]

European Journal of Clinical Investigation, 2010
Eur J Clin Invest 2010; 40 (8): 742–755AbstractBackground Advanced glycation end‐products (AGEs) are increased in situations with hyperglycemia and oxidative stress such as diabetes mellitus. They are products of nonenzymatic glycation and oxidation of proteins and lipids.
Martin Büsch, Sybille Franke, Christiane Ruster   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Advanced glycation end products in uremia

Advances in Renal Replacement Therapy, 2003
The term "advanced glycation end products" (AGEs) stands for a heterogeneous group of amino acid derivatives that are formed via glycation processes between peptide-bound lysine or arginine derivatives and carbonyl compounds, processes originally known from food systems as "Maillard reactions." AGEs accumulate in plasma and tissues with advancing age ...
Thomas, Henle, Toshio, Miyata
openaire   +2 more sources